Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study/Experiment 2
From BugSigDB
Reviewed Marked as Reviewed by Lwaldron on 2022/03/28
Subjects
- Location of subjects
- Austria
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Dementia dementia,dementia (disease),Dementia
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Controls without cognitive impairments
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Patients with dementia
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Participants with any level of dementia (mild, moderate, severe).
- Group 0 sample size Number of subjects in the control (unexposed) group
- 18
- Group 1 sample size Number of subjects in the case (exposed) group
- 23
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- 4 weeks
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V1-V2
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Statistical test
- LEfSe
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- No
- Matched on Factors on which subjects have been matched on in a case-control study
- age, sex
Alpha Diversity
- Chao1 Abundance-based estimator of species richness
- unchanged
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
Signature 1
Reviewed Marked as Reviewed by Lwaldron on 2022/03/28
Source: 3a
Description: Differentially abundant taxa between any level of dementia vs controls
Abundance in Group 1: increased abundance in Patients with dementia
| NCBI | Quality Control | Links |
|---|---|---|
| Anaerostipes hadrus | ||
| Clostridiales bacterium | ||
| Enterocloster clostridioformis | ||
| Lachnoclostridium | ||
| Phocaeicola dorei | ||
| [Ruminococcus] torques |
Revision editor(s): Lwaldron, Maryemzaki
Signature 2
Reviewed Marked as Reviewed by Lwaldron on 2022/03/28
Source: Figure 3a
Description: Differentially abundant taxa between any level of dementia vs controls
Abundance in Group 1: decreased abundance in Patients with dementia
Revision editor(s): Lwaldron, Maryemzaki
